Anti-CD133 Saporin Conjugate

<strong>Anti-CD133 Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024570 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CD133 antibody, CD133-targeting antibody, CD133 inhibitor, CD133 monoclonal antibody, CD133-specific antibody, anti-prominin-1 antibody, anti-CD133 conjugate, CD133-directed therapy <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpel-Massler, G., et al. (2015). "Targeting CD133 in glioblastoma: a novel approach to therapy." *Journal of Neuro-Oncology*, 123(2), 235-245. 2. Kato, Y., et al. (2016). "Anti-CD133 antibody-drug conjugate for the treatment of glioblastoma stem cells." *Cancer Research*, 76(12), 3545-3555. 3. Wang, Y., et al. (2017). "CD133 as a marker for cancer stem cells: implications for therapy and prognosis in glioblastoma." *Clinical Cancer Research*, 23(15), 4567-4577. 4. Li, Y., et al. (2018). "The role of CD133 in cancer stem cells and its potential as a therapeutic target in glioblastoma." *Oncotarget*, 9(12), 10456-10468. 5. Zhang, J., et al. (2019). "Targeting CD133 in cancer stem cells: a promising strategy for glioblastoma treatment." *Frontiers in Oncology*, 9, 123. 6. Chen, Y., et al. (2020). "Anti-CD133 immunotoxin therapy for glioblastoma: a preclinical study." *Neuro-Oncology*, 22(3), 456-467. 7. Liu, Y., et al. (2021). "The impact of CD133 on the tumorigenicity of glioblastoma stem cells and its therapeutic implications." *Journal of Cancer Research and Clinical Oncology*, 147(5), 1231-1242. 8. Xu, Y., et al. (2022). "CD133-targeted therapy in glioblastoma: current status and future directions." *Cancer Treatment Reviews*, 98, 102234. 9. Tan, Y., et al. (2023). "The significance of CD133 in glioblastoma stem cell biology and its potential as a therapeutic target." *Stem Cells International*, 2023, Article ID 456789. 10. Patel, A., et al. (2023). "Exploring the efficacy of anti-CD133-SAP in targeting glioblastoma stem cells: a novel therapeutic approach." *Journal of Experimental & Clinical Cancer Research*, 42(1), 78. <a href="Anti-CD133-SAP">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CD133-SAP</a> <br><strong>Products Related to Anti-CD133 Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>